POAI - LICY POAI and SGMA among pre market gainers
ZIVO Bioscience (NASDAQ:ZIVO) +81%. Meredith Corporation (NYSE:MDP) +16% on report IAC is in purchase talks Capricor Therapeutics (NASDAQ:CAPR) +26% on positive CAP-1002 data from mid-stage duchenne muscular dystrophy study vTv Therapeutics (NASDAQ:VTVT) +21% on ascending dose study data, plans for phase 2 trial Aehr Test Systems (NASDAQ:AEHR) +18% on Q1 earnings. Unique Fabricating (NYSE:UFAB) +15%. Li-Cycle (NYSE:LICY) +8%. Uxin (NASDAQ:UXIN) +8% on Q1 earnings. Focus Universal (NASDAQ:FCUV) +8%. Predictive Oncology (NASDAQ:POAI) +7%. SigmaTron International (NASDAQ:SGMA) +3%.
For further details see:
LICY, POAI and SGMA among pre market gainers